Letter To The Editor
Copyright ©The Author(s) 2018.
World J Gastrointest Oncol. Dec 15, 2018; 10(12): 528-531
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.528
Figure 1
Figure 1 Spider plots of the response to 1st-line FOLFOXIRI plus bevacizumab in patients with RAS mutation (JACCRO CC-11). A: Spider plots of tumor burden changes in patients with left-sided tumors (n = 44); B: Spider plots of tumor burden changes in patients with right-sided tumors (n = 17).